Novartis AG (NYSE:NVS) closed its last session at $79.11 with the change of -0.01%. The market capitalization of the company is $188.38B with an average Volume of 1.47 million shares. The stock currently has its 52-Week High range of $98.95 and 52-week low range of $69.90. The Price to Book (P/B) ratio stands at 2.60. The stock traded total quantity of 1.2 million shares.
Currently Novartis AG (NVS) captured an average recommendation of “ Overweight ” from analysts, according to FactSet data. The stock has been suggested as “Buy” from “11″ Analysts”. “1” rated “Sell” for the company. “17” said the company as a “Hold”. Overweight rating was given by “2” and Underweight rating was given by “0”.
Analysts are expecting that the company to achieve $89.72 Price Target in next 52-weeks, average price is come up through the consensus of analysts. High potential price target is set at $115.00 however minimum price target advised by analysts is $76.06. The Median price target for the stock is measured at $86.84.
Presently, Analysts decided consensus EPS estimate of $1.19 for present quarter and one month ago projected EPS estimate was at $1.19. If we take a look at back 3 month ago, consensus EPS estimate was $1.23.
A current consensus EPS estimate for next quarter is at $1.17 and 3 month ago EPS forecast was $1.21. Have a look at back 1 month ago, consensus EPS forecast was seen at $1.17.
For current fiscal year, most recent EPS estimate is set at $4.71 based on Analyst consensus and three month ago consensus EPS opinions was at $4.69. During period one month ago, consensus EPS forecast was decided at $4.69.
A current consensus EPS projection for next fiscal year is observed at $5.07 and one month ago consensus EPS forecast was at $5.05. Take a look at back three month ago, consensus EPS estimate opinions was decided at $5.10 by analysts.
One Month ago, the stock has gained consensus mean rating of Overweight based on the analysis of brokerage analyst firms polled. 12 presented the recommendations about the stock as a “Buy” signal and “Overweight” signal was reported by 2. 17 advised the “Hold” rating about this stock. 1 revealed “Sell” signal and “Underweight” rating was declared by 0.
Three Months Ago, Analysts recommended an average brokerage rating of Overweight derived from brokerage firms, according to FactSet. 11 said a “Buy Rating” and 2 announced “Overweight Rating”. 17 advised “Hold Rating” regarding the stock. 1 announced “Sell Rating” and 0 disclosed “Underweight Rating”.